Skip to main content
SpringerLink
Log in

A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS)

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BA, Tak PP, Wolbink GJ (2007) Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis 66(7):921–926

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Karmiris K, Paintaud G, Noman M, Magdelaine-Beuzelin C, Ferrante M, Degenne D, Claes K, Coopman T, Van Schuerbeek N, Van Assche G, Vermeire S, Rutgeerts P (2009) Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn’s disease. Gastroenterology 137(5):1628–1640

    Article  PubMed  CAS  Google Scholar 

  3. Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2009) Phase I trial of rosiglitazone in FSGS: I. Report of the FONT study group. Clin J Am Soc Nephrol 4(1):39–47. doi:10.2215/CJN.02310508

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2010) Phase 1 trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis 55(1):50–60

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Ternant D, Ducourau E, Fuzibet P, Vignault C, Watier H, Lequerre T, Xavier LL, Vittecoq O, Goupille P, Mulleman D, Paintaud G (2014) Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis. Br J Clin Pharmacol 2014(16):12509

    Google Scholar 

  6. Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G (2015) Pharmacokinetics of adalimumab in Crohn’s disease. Eur J Clin Pharmacol 2015:27

    Google Scholar 

  7. Fasanmade AA, Adedokun OJ, Blank M, Zhou H, Davis HM (2011) Pharmacokinetic properties of infliximab in children and adults with Crohn’s disease: a retrospective analysis of data from 2 phase III clinical trials. Clin Ther 33(7):946–964

    Article  PubMed  CAS  Google Scholar 

  8. Robbie GJ, Zhao L, Mondick J, Losonsky G, Roskos LK (2012) Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children. Antimicrob Agents Chemother 56(9):4927–4936

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Edlund H, Melin J, Parra-Guillen ZP, Kloft C (2015) Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children. Clin Pharmacokinet 54(1):35–80

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was a reanalysis of data that were already published. No financial disclosure has to be declared. This work was partly supported by the French Higher Education and Research ministry under the program ‘Investissements d’avenir’ Grant Agreement: LabEx MAbImprove ANR-10-LABX-53-01.

Contribution of authors statement

D. Ternant analysed and interpreted the data and wrote the manuscript. G. Paintaud participated in data interpretation and in the writing of the manuscript. H. Trachtman and D. Gipson participated actively in the execution of the study. M. Joy conceived the ideas and experimental design and participated actively in the execution of the study and in the writing of the manuscript.

Author information

Authors and Affiliations

  1. CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Université François-Rabelais de Tours, 2 boulevard Tonnellé, 37044, Tours Cedex, France

    David Ternant & Gilles Paintaud

  2. Division of Nephrology, NYU Langone Medical Center, New York, NY, USA

    Howard Trachtman

  3. School of Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA

    Debbie S. Gipson

  4. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA

    Melanie S. Joy

Authors
  1. David Ternant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gilles Paintaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Howard Trachtman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Debbie S. Gipson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melanie S. Joy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Ternant.

Ethics declarations

Conflict of interest

Dr. Ternant, Dr. Trachtman and Dr. Joy declare that they have no competing interests.

Dr. Paintaud reports grants from Novartis, grants from Roche Pharma, grants from Genzyme, grants from MSD, grants from Servier and grants from Pfizer, outside the submitted work.

Dr. Gipson reports other grants from GSK and Retrophin outside the submitted work.

Electronic supplementary material

ESM 1

(DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ternant, D., Paintaud, G., Trachtman, H. et al. A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS). Eur J Clin Pharmacol 72, 253–255 (2016). https://doi.org/10.1007/s00228-015-1973-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1973-1

Keywords

Search

Navigation